CSATVB Scientific Excellence Award 2011
"The CSATVB Scientific Excellence Award" is sponsored by the Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology. An Award of $2000 is given to an active researcher for consistently outstanding and innovative research in the areas of atherosclerosis, thrombosis and/or vascular biology. The award is open to Canadian citizens or landed immigrants in Canada who are faculty members of a Canadian university or are staff members of a recognized Canadian research institute or equivalent. The deadline for receipt of letters of nomination is September 8, 2010. The letter should explain why the nominee is deserving of the award and include an up-to-date full CV of the candidate. Please send nominations (electronically) to: Dr. Avrum I. Gotlieb Chair, CSATVB Scientific Excellence Award Professor, Department of Laboratory Medicine and Pathobiology Vice Dean, Research and International Relations (Interim) Faculty of Medicine, University of Toronto 101 College Street, East Tower, Room 3-313 Toronto, Ontario M5G 1L7 Email: avrum.gotlieb@utoronto.ca The award will consist of a cheque for $2000, a commemorative plaque, and free membership to CSATVB for 1 year. The awardee is expected to deliver a keynote scientific lecture at the annual CSATVB Scientific meeting held at the Canadian Cardiovascular Congress. Nominees for this award are now being sought. Please distribute widely and consider making a nomination yourself. All nomination letters will be acknowledged. Avrum I. Gotlieb MDCM, FRCPC Chair, CSATVB Scientific Excellence Award January 25, 2010
WINNERS
2010:Dr. Philip Marsden of University of Toronto, Toronto, ON 2009:Dr. Bruce McManus of University of British Columbia, Vancouver, BC
Dr. Bruce McManus is the 2nd recipient of the CASTVB Scientific Excellence Award (2009).
Dr. McManus received his PhD in Exercise Physiology and Biochemistry at the University of Toledo and his MD at the University of Saskatchewan. He trained as an Anatomic Pathologist at HarvardMedicalSchool and did his fellowship training at the NHLBI in Bethesda. Dr. Bruce McManus has made an enormous impact on cardiovascular research at the local, provincial, national and international levels. Since Dr. McManus was recruited back to Canada in 1993 as the UBC Department Head of Pathology and Laboratory Medicine, he has devoted his life to research, research administration and training the future generations of biomedical researchers. He went from being the Department Head of Pathology and Laboratory Medicine to founding and co-directing the James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research. He then became the inaugural Scientific Director of the CIHR Institute for Circulatory and Respiratory Health. Dr. McManus made significant contributions to the development and growth of the iCAPTURE Centre as he has played a monumental role in shaping this Centre and to the raising of millions of dollars in funding for research and education. He founded and directed the Providence Heart and Lung Institute at St. Paul’s Hospital. Although Dr. McManus has clearly established himself as an international leader in cardiovascular research, he is also an outstanding mentor and continually puts the needs of his trainees at the top of his list with his open door policy and addressing any problems they may encounter. Often this means meeting with trainees on the weekends, early mornings or evenings. As such, his commitment to research, whether at the individual trainee level or leading the country’s national cardiovascular and pulmonary agenda, is commendable. Dr. McManus has made numerous ground-breaking discoveries pertaining to viral myocarditis, and to chronic transplant rejection among other topics that have resulted in over 300 publications, hundreds of invited talks and numerous awards. His myocarditis work has revolutionized our understanding of viral cardiomyopathy with respect to establishing a role for the direct cytopathic effect of coxsackievirus B3 on cardiac myocytes and how this pertains to the pathogenesis of viral cardiomyopathies. In addition, his work showing the importance of blood lipids as a risk factor for cardiac allograft vasculopathy, the leading cause of organ failure in transplant recipients that survive greater than one year after transplantation. Dr. McManus is also one of the lead investigators on a large Genome Canada grant to develop biomarkers to detect and predict early and chronic transplant rejection in liver, kidney and heart recipients.
2008:Dr. André Marette of Laval University, Québec, QC

The 1st annual CSATVB Scientific Excellence Award will be presented at the annual meeting in Toronto as part of Canadian Cardiovascular Congress in October, 2008.
The awardee is Professor Andre Marette, PhD, a full Professor in the department of Anatomy and Physiology. Dr.Marette graduated from LavalUniversity in 1990 with a PhD in Physiology and Endocrinology. After post-doctoral training in cell biology with Dr. Amira Klip and Dr.MladenVranic at the University of Toronto, he joined the Québec Lipid Research Centre (CRML) and LavalUniversity. He is presently a FRSQ National Scientist. Dr. Marette is an international expert on the pathogenesis of insulin resistance in altered metabolic states and on the mechanisms by which exercise improves muscle metabolism. He has advanced the understanding of cellular/molecular defects leading to diabetes and opened new possibilities for pharmacological interventions. Some of his important scientific contributions include:
• Identification of nitric oxide as a novel modulator of insulin action in insulin target cells; • Discovery that dietary fish proteins and omega-3 PUFA modulate obesity-linked insulin resistance; • Demonstration that the mTOR/S6K1 pathway operates a nutrient-sensing negative feedback loop regulating insulin signaling to glucose metabolism; • Novel mechanisms of regulation of muscle glucose transport by insulin and contraction; and • Finding a novel role for the protein tyrosine phosphatase SHP-1 as a negative modulator of insulinmediated glucose metabolism and hepatic insulin clearance. Dr. Marette has published over 100 papers in high-impact journals. He is currently Associate Editor at the American Journal of Physiology: Endocrinology & Metabolism section and also serves as internal or external referee to a number of international and national funding agencies. Dr. Marette has received several national and international research awards and honors. He is currently leading a CIHR-funded team grant on the cardiovascular complications of diabetes. He also holds a Pfizer Canada/CIHR research Chair in the pathogenesis of insulin resistance and cardiovascular diseases. He has received several awards including the prestigious Young Scientist Award of the Canadian Diabetes Association and the Charles Best Lectureship Award of the University of Toronto, both in recognition for his outstanding contribution to diabetes research.
|